Tobias Cantz

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Journal: Human gene therapy

Published: July 07, 2026

Functional inactivation of MDR3 caused by a homozygous ABCB4 missense variant leading to liver failure.

Functional inactivation of MDR3 caused by a homozygous ABCB4 missense variant leading to liver failure.

Journal: Frontiers in genetics

Published: February 02, 2026

Nucleoside-Modified mRNA Encoding Alpha-Galactosidase A Ameliorates Fabry Disease Phenotypes in Human IPSC-Derived Cardiomyocytes.

Nucleoside-Modified mRNA Encoding Alpha-Galactosidase A Ameliorates Fabry Disease Phenotypes in Human IPSC-Derived Cardiomyocytes.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 12, 2025

Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver disease.

Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver disease.

Journal: Journal of hepatology

Published: September 18, 2025

In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.

In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.

Journal: Journal of hepatology

Published: July 15, 2025

"Snip, snip, cure"? Philosophical, legal and biomedical perspectives on novel somatic genomic therapies.

"Snip, snip, cure"? Philosophical, legal and biomedical perspectives on novel somatic genomic therapies.

Journal: Medicine, health care, and philosophy

Published: June 30, 2025

PAM-interacting domain turn-helix 51 motifs can improve Cas9-SpRY activity.

PAM-interacting domain turn-helix 51 motifs can improve Cas9-SpRY activity.

Journal: Nucleic acids research

Published: May 13, 2025

A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis.

A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis.

Journal: The Journal of biological chemistry

Published: April 28, 2025

iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis.

iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis.

Journal: Hepatology communications

Published: April 25, 2025

Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosis.

Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosis.

Journal: Journal of hepatology

Published: January 14, 2024

Generation of Human 293-F Suspension NGFR Knockout Cells Using CRISPR/Cas9 Coupled to Fluorescent Protein Expression.

Generation of Human 293-F Suspension NGFR Knockout Cells Using CRISPR/Cas9 Coupled to Fluorescent Protein Expression.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 05, 2023

Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.

Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.

Journal: Cell reports. Medicine

Published: May 17, 2023

Showing 1-12 of 71

Last Updated: 09/26/2026